SCHEMBL3942860

SCHEMBL3942860

C[C@@](O)(C(=O)O)C(=O)NCC(F)(F)F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.35
TSHR P16473 1/20 0.35
PGK1 P00558 1/20 0.33
PGK2 P07205 1/20 0.33
CTSS P25774 1/20 0.33
CTSK P43235 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
KDM4E B2RXH2 1/20 0.32
HPGD P15428 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
POLB P06746 2/20 0.31
LMNA P02545 2/20 0.31
PDK1 Q15118 2/20 0.31
PDK2 Q15119 2/20 0.31
PDK3 Q15120 2/20 0.31
PDK4 Q16654 2/20 0.31
HTT P42858 1/20 0.30
HMGCR P04035 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1562256 1.00 ALDH1A1 (0.35) ALDH1A1TSHRPGK1PGK2CTSS
SCHEMBL1562258 1.00 ALDH1A1 (0.35) ALDH1A1TSHRPGK1PGK2CTSS
SCHEMBL3939178 0.84 PSEN1 (0.34) ALDH1A1TSHRPGK1PGK2PDK1
SCHEMBL1562887 0.84 PSEN1 (0.34) ALDH1A1TSHRPGK1PGK2PDK1
SCHEMBL15271680 0.82 PGK1 (0.38) ALDH1A1PGK1PGK2CTSSCTSK
SCHEMBL1562473 0.82 PGK1 (0.32) ALDH1A1PGK1PGK2MEN1KMT2A
SCHEMBL1562477 0.82 PGK1 (0.32) ALDH1A1PGK1PGK2MEN1KMT2A
SCHEMBL1562086 0.80 ALDH1A1 (0.38) ALDH1A1TSHRPGK1PGK2MEN1
SCHEMBL3934762 0.80 ALDH1A1 (0.38) ALDH1A1TSHRPGK1PGK2MEN1
SCHEMBL1562308 0.80 MMP8 (0.39) ALDH1A1MEN1KMT2AKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2018368-B1 MALONAMIDE DERIVATIVES AS GAMMA SECRETASE INHIBITORS HOFFMANN LA ROCHE (CH) 2012-12-05 EP disclosed
EP-2109604-A1 6-OXO-6,7-DIHYDRO-5H-DIBENZO[B,D]AZEPIN-7-YL DERIVATIVES F. Hoffmann-Roche AG (CH) 2009-10-21 EP disclosed
US-7544679-B2 6-oxo-6,7-dihydro-5h-dibenzo[b,d]azepin-7-yl derivatives HOFFMAN-LA ROCHE INC. (US) 2009-06-09 US disclosed
US-7425551-B2 Malonamide derivatives HOFFMANN-LA ROCHE INC. (US) 2008-09-16 US disclosed
WO-2008092786-A1 6-OXO-6,7-DIHYDRO-5H-DIBENZO[B,D]AZEPIN-7-YL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2008-08-07 WO disclosed
US-20080188463-A1 6-OXO-6,7-DIHYDRO-5H-DIBENZO[B,D]AZEPIN-7-YL DERIVATIVES HOFFMANN-LA ROCHE, INC. 2008-08-07 US disclosed
US-20070225273-A1 Malonamide derivatives F. HOFFMANN-LA ROCHE AG (CH) 2007-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225273-A1 Malonamide derivatives ACE, APP, NAAA ALDH1A1 92/4885TSHR 1918/4885PGK1 3002/4885
US-20080188463-A1 6-OXO-6,7-DIHYDRO-5H-DIBENZO[B,D]AZEPIN-7-YL DERIVATIVES BACE1, BACE2, APH1B ALDH1A1 795/4885TSHR 4173/4885PGK1 3242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.